Activia

Uses your system voice; voice and rate in settings.

Snapshot

≈ 4 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Activia is a brand of yogurt owned by Groupe Danone (Dannon in the United States) and introduced in France in 1987. As of 2013, Activia is present in more than 70 countries and on 5 continents. Activia is classified as a functional food, designed to improve digestive health. In the 1980s, Danone researchers took interest in bifidobacteria. They developed a specific strain that can survive in the acidic medium of yogurt. In addition to traditional yogurt bacteria, they decided to add a probiotic strain. Activia products thus contain Bifidobacterium animalis DN 173,010, a proprietary strain of Bifidobacterium, a probiotic which is marketed by Dannon under the trade names Bifidus Regularis, Bifidus Actiregularis, Bifidus Digestivum and Bifidobacterium Lactis. Danone launched Activia in France in 1987 under the "Bio" brand name. The claims of health benefits have led to lawsuits in the European Union, Canada, and the United States, all of which have resulted in Danone having to modify their advertisement and pay compensations to customers.

Activia is a brand of yogurt owned by Groupe Danone (Dannon in the United States) and introduced in France in 1987. As of 2013, Activia is present in more than 70 countries and on 5 continents. Activia is classified as a functional food, designed to improve digestive health. In the 1980s, Danone researchers took interest in bifidobacteria. They developed a specific strain that can survive in the acidic medium of yogurt. In addition to traditional yogurt bacteria, they decided to add a probiotic strain. Activia products thus contain Bifidobacterium animalis DN 173,010, a proprietary strain of Bifidobacterium, a probiotic which is marketed by Dannon under the trade names Bifidus Regularis, Bifidus Actiregularis, Bifidus Digestivum and Bifidobacterium Lactis. Danone launched Activia in France in 1987 under the "Bio" brand name. The claims of health benefits have led to lawsuits in the European Union, Canada, and the United States, all of which have resulted in Danone having to modify their advertisement and pay compensations to customers.

Introductions into new countries

1987: France 1988: Belgium, Spain, and the United Kingdom 1989: Italy 2002: Russia, Japan 2004: Brazil, and Canada 2005: Africa, China, and the United States 2009: South Korea 2011: Australia By 2006, the brand was operating in 22 countries. In 2013, it was sold in more than 70 countries.

The probiotics market

Activia products are considered as functional foods. These foods are enriched with probiotics and provide health benefits when consumed in adequate amounts. The positive effects depend on the specific strain and its dose. In 2003, the probiotics (also called functional foods) market was worth $9.9 billion. These products are also heavily marketed and more expensive than non-probiotic dairy products. In 2009, in the United Kingdom, 60% of households regularly bought probiotic drinks. The market there is currently worth £164m per year. Consumers are willing to pay for products that provide health benefits. Activia products, that are considered as functional foods, are priced higher than other yogurts.

Debates surrounding health claims on probiotic foods

While indicating Bifidobacterium lactis, the package does not list that Activia also contains strains commonly found in Yogurt: Lactobacillus bulgaricus, Streptococcus thermophilus (that produce high amounts of biogenic amines, poorly tolerated by people with histamine intolerance) and Lactococcus lactis. Some experts say there is evidence that probiotic strains reduce diarrhea, irritable bowel syndrome and duration of colds. But others argue that their benefits are not certain. The US FDA pressed charges for false advertising. According to Danone, Activia is based on 17 scientific studies. But according to CBS News, two of these studies were not statistically significant compared to the placebo groups and six others did not show a statistically significant improvement in transit time.

References

External links

whatisbifidusregularis.org/ – An analysis of the terms Bifidus Actiregularis, Bifidus Regularis, Bifidus Digestivum, L. Casei Immunitass and their variants, as well as the marketing strategy, and information about the potential health benefits of live yogurts.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1354322297 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

31 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.